Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/13/2025

IV Fluid Administration in CKD Stage 4

Key Principles for IV Fluid Management

  • The American Journal of Kidney Diseases recommends administering IV fluids with extreme caution and only when clinically indicated, using isotonic crystalloids (preferably 0.9% sodium chloride) at reduced volumes to avoid fluid overload, which is associated with increased morbidity and mortality 1
  • For radiocontrast procedures, administer 0.9% sodium chloride at 1 mL/kg/h for 6-12 hours before and after contrast administration to prevent contrast-induced nephropathy, though use extreme caution regarding total volume in advanced CKD 1
  • The American Journal of Kidney Diseases suggests that 0.9% sodium chloride is superior to 0.45% sodium chloride for preventing radiocontrast nephropathy and is the preferred isotonic crystalloid 1
  • Reduce standard volumes by 30-50% compared to patients with normal kidney function 1
  • Avoid hypotonic solutions (0.45% saline, D5W) as they provide inadequate sodium and increase risk of hyponatremia 1
  • Discontinue nephrotoxic medications (NSAIDs, aminoglycosides, amphotericin) before administering IV fluids for procedures 1
  • In radiocontrast procedures, limit contrast volume to <30 mL in patients with eGFR <30 mL/min/1.73 m² to prevent acute kidney failure 1

When to RESTRICT Fluids

  • Fluid restriction is mandatory in CKD stage 4 patients who are oliguric or anuric (urine output <400 mL/day) 2, 3
  • Fluid restriction is mandatory in CKD stage 4 patients who are showing signs of fluid overload (peripheral edema, pulmonary congestion, hypertension) 2, 3

Conservative Management Alternative

  • For CKD stage 4 patients not requiring dialysis, conservative fluid management with oral intake optimization and diuretic therapy (loop diuretics) is preferred over routine IV fluid administration to maintain volume homeostasis 3, 4